Half of America Is Now "Sick" According to Big Pharma

Mike, BergmanAugust 13, 2026

 A New Guideline Changes Everything

In March 2026, a major new cholesterol guideline was published by the American College of Cardiology and the American Heart Association. A few months later, in July 2026, a separate population analysis published in JAMA made headlines around the world: an estimated 87.5 million U.S. adults between the ages of 30 and 79 — roughly 56.6 percent of that population — now meet the criteria to be considered for statin therapy to prevent a first heart attack or stroke.

That number stopped a lot of people in their tracks. Does this mean more than half of Americans are suddenly sick? Did the country's health collapse overnight?

The short answer is: no. Being "eligible" for a medication is not the same as having a disease. The guidelines changed where the line is drawn, not the underlying biology of the people standing near that line. About 21.5 million of those newly eligible adults had a mean estimated 10-year heart risk of only about 3.1 percent — meaning their short-term risk was comparatively low (Moran et al., 2024; Becker's Cardiology, 2026).

Still, the headline raises a real and important question: What is driving the push to expand treatment to so many people, and what can you do to genuinely protect your own heart health? That is exactly what this article is here to answer.